PATHOPHYSIOLOGY AND TREATMENT IN SICKLE CELL DISEASE--STROKE PREVENTION TRIAL

镰状细胞病的病理生理学和治疗——中风预防试验

• 批准号: 6308636
• 负责人: ELLIOTT P VICHINSKY
• 金额: $ 2.58万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-12-01 至 2000-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6308636
• 关键词: bioimaging /biomedical imaging; blood transfusion; clinical research; disease /disorder proneness /risk; human subject; human therapy evaluation; sickle cell anemia; stroke; ultrasound blood flow measurement

Transcranial Doppler has been developed as a noninvasive method of predicting stroke risk. This is a screening program, using Transcranial Doppler, and treatment strategy, using chronic transfusion therapy, that could prevent brain injury and disability or death from first time ischemic stroke in young children with sickle cell disease.

经颅多普勒已被开发为预测中风风险的无创方法。 这是一项使用经颅多普勒的筛查计划和使用慢性输血疗法的治疗策略，可以预防患有镰状细胞病的幼儿因首次缺血性中风而造成的脑损伤和残疾或死亡。